title: The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
abstract: Increasing epidemiological studies have revealed the important role of methylenetetrahydrofolate reductase (MTHFR) in carcinogenesis. The association of MTHFR A1298C and MTHFR C677T polymorphisms with the risk for gastric cancer remains obscure due to inconsistent findings in independent studies among diverse ethnicities. A meta-analysis based on all available publications on this genetic association was performed. The pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated to estimate the effect of MTHFR variants on gastric carcinogenesis. Totally, 25 eligible case-control studies were included into the meta-analysis according to the inclusion criteria. The MTHFR C677T polymorphism was demonstrated to significantly increase the susceptibility to gastric cancer (OR(T vs. C) = 1.21, 95% CI 1.10-1.34; OR(TT vs. CC )= 1.47, 95% CI 1.22-1.76; OR(TC vs. CC )= 1.20, 95% CI 1.03-1.40; OR(TT + TC vs. CC) = 1.27, 95% CI 1.10-1.47; OR(TT vs. CC + TC )= 1.29, 95% CI 1.15-1.46), whereas no significant correlation was observed when assessing the MTHFR A1298C polymorphism (OR(C vs. A )= 1.00, 95% CI 0.90-1.10; OR(CC vs. AA) = 0.99, 95% CI 0.75-1.31; OR(CA vs. AA )= 1.01, 95% CI 0.89-1.14; OR(CC + CA vs. AA) = 1.00, 95% CI 0.89-1.13; OR(CC vs. AA + CA) = 0.97, 95% CI 0.74-1.27). Subgroup analyses by ethnicity and source of controls further confirmed the findings in overall analysis. The meta-analysis suggests that the polymorphism of MTHFR C677T but not MTHFR A1298C confers a risk effect on the development of gastric cancer among Asians and Caucasians, which provides a new insight into the gastric cancer pathogenesis.
authors.affiliation: Liver Transplantation Center of the First Affiliated Hospital, Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
authors.forename: Long
authors.initials: L
authors.lastname: Lv
authors.forename: Ping
authors.initials: P
authors.lastname: Wang
authors.forename: Beicheng
authors.initials: B
authors.lastname: Sun
authors.forename: Gong
authors.initials: G
authors.lastname: Chen
mesh_terms: D000483:Alleles; D016022:Case-Control Studies; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D017594:Publication Bias; D013274:Stomach Neoplasms / Q000208:ethnology / Q000235:genetics*
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2)
references.citation: Tumour Biol. 2013 Oct;34(5):3049-57
references.pmid: 23765761
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Cancer Causes Control. 2007 Mar;18(2):143-52
references.pmid: 17206530
references.citation: World J Gastroenterol. 2012 Oct 7;18(37):5164-70
references.pmid: 23066309
references.citation: Dis Esophagus. 2005;18(3):177-84
references.pmid: 16045580
references.citation: Oncol Rep. 2005 Feb;13(2):355-60
references.pmid: 15643524
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: World J Surg. 1995 Jul-Aug;19(4):484-8; discussion 489-90
references.pmid: 7676688
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):115-21
references.pmid: 17220339
references.citation: Oncol Lett. 2012 Aug;4(2):365-369
references.pmid: 22844384
references.citation: Tumour Biol. 2010 Jan;31(1):23-32
references.pmid: 20237899
references.citation: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references.pmid: 13655060
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Blood. 2005 Jul 15;106(2):717-20
references.pmid: 15797993
references.citation: Iran Biomed J. 2012;16(4):179-84
references.pmid: 23183616
references.citation: Clin Oncol (R Coll Radiol). 2012 May;24(4):269-81
references.pmid: 21489764
references.citation: IARC Sci Publ. 2004;(157):327-49
references.pmid: 15055305
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1454-8
references.pmid: 12433726
references.citation: Eur J Nutr. 2009 Aug;48(5):269-76
references.pmid: 19288150
references.citation: Cell Biochem Funct. 2007 Jul-Aug;25(4):419-22
references.pmid: 16927418
references.citation: Mol Vis. 2013 May 06;19:1006-16
references.pmid: 23687437
references.citation: Pediatr Blood Cancer. 2012 Apr;58(4):513-8
references.pmid: 21495160
references.citation: Toxicol Lett. 2009 Jan 30;184(2):73-80
references.pmid: 18840514
references.citation: Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):794-9
references.pmid: 16536307
references.citation: Biometrika. 1950 Dec;37(3-4):256-66
references.pmid: 14801052
references.citation: Arch Med Res. 2010 Feb;41(2):125-33
references.pmid: 20470942
references.citation: Int J Cancer. 2006 Feb 1;118(3):628-32
references.pmid: 16094648
references.citation: Eur J Cancer. 2006 Mar;42(4):528-33
references.pmid: 16359859
references.citation: Anticancer Res. 2012 Sep;32(9):3715-21
references.pmid: 22993310
references.citation: Cancer Lett. 2007 Jun 28;251(2):228-36
references.pmid: 17208363
references.citation: World J Gastroenterol. 2006 Dec 21;12(47):7591-7
references.pmid: 17171786
references.citation: Future Oncol. 2009 May;5(4):523-42
references.pmid: 19450180
references.citation: Rev Gastroenterol Mex. 2007 Oct-Dec;72(4):355-8
references.pmid: 18595323
references.citation: Nat Genet. 1995 May;10(1):111-3
references.pmid: 7647779
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2416-24
references.pmid: 18006931
references.citation: Zhonghua Liu Xing Bing Xue Za Zhi. 2002 Aug;23(4):289-92
references.pmid: 12411076
references.citation: Mol Genet Metab. 1998 Jul;64(3):169-72
references.pmid: 9719624
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1222-6
references.pmid: 14652285
references.citation: Med Hypotheses. 2013 May;80(5):679-83
references.pmid: 23490201
references.citation: Anticancer Res. 2005 May-Jun;25(3B):2249-52
references.pmid: 16158971
references.citation: Scand J Gastroenterol. 2005 Jan;40(1):109-11
references.pmid: 15841723
references.citation: J Nanosci Nanotechnol. 2007 Sep;7(9):3245-9
references.pmid: 18019157
references.citation: DNA Cell Biol. 2013 May;32(5):260-7
references.pmid: 23578207
references.citation: Biomarkers. 2007 Jan-Feb;12(1):61-75
references.pmid: 17438654
references.citation: World J Gastroenterol. 2012 May 7;18(17):2112-20
references.pmid: 22563200
references.citation: J Cancer Epidemiol. 2012;2012:952508
references.pmid: 23125859
references.citation: Biomarkers. 2007 Nov-Dec;12(6):635-44
references.pmid: 17972183
references.citation: BMC Cancer. 2010 May 26;10:236
references.pmid: 20504332
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120